Contact Us | Sitemap
logo
About ISTA Products Pipeline Careers Investors

Image
ISTA Investor Information


BROMDAY™

(bromfenac ophthalmic solution) 0.09%
 

BEPREVE
BEPREVE®

(bepotastine besilate
ophthalmic solution) 1.5%
 

Istalol
Istalol®

(timolol maleate
ophthalmic solution) 0.5%
 

Investor Highlights

Presentations
Stock Quotes
Quarterly Fact sheet

Products

BROMDAY

BEPREVE

Istalol

Vitrase
 

Press Releases

  • ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
  • ISTA Pharmaceuticals Reports First Quarter 2012 Financial Results
  • ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of BEPOSONE(TM) Nasal Spray for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis
Top | Contact Us | Products | MSDS | Disclaimer | Sitemap | Educational Grant Requests

© 2012 ISTA Pharmaceuticals, Inc.